KDV B — Kdventures AB Share News
0.000.00%
Last trade - 00:00- SEK185.53m
- SEK138.12m
- SEK1.67m
Brief: Karolinska Development Implements Organizational Changes
Brief: Karolinska Development Portfolio Co Secures Bridge Financing
Brief: Umecrine Cognition Shows Positive Interim Results in Phase 1B/2A Study
Brief: Karolinska Development Q3 Net Income SEK -10.9 Million
Brief: Karolinska Development Portfolio Co Boost Pharma Completes Pre-Ind Meeting With FDA, Gets Second Tranche Of Investment
Brief: Karolinska Development Divests Its Holding In Danish Dermatology Company Henlez
Brief: Karolinska Development Portfolio Company Boost Pharma Announces Positive Top-Line Results From Phase 1/2 Study
Brief: Karolinska Development Q2 Net Income SEK -16 Million
Brief: Karolinska Development Invests In Boost Pharma
Brief: Karolinska Development Q1 Sales SEK 500 Thousand
Brief: Karolinska Development Proposes Hans Wigzell As Chairman
Brief: Karolinska Development’s Portfolio Company Presents Positive Safety Data From First Part Of Phase 1b/2 Study In PBC
Brief: Karolinska Development Q4 Net Result Swings To Loss Of SEK 1.9 Million
Brief: Karolinska Development: Portfolio Company Pharmnovo's Drug Candidate PN6047 In NIDA Funded Collaboration
Brief: Karolinska Development Q3 Net Sales Down At SEK 0.4 Mln
Brief: Karolinska Development's Portfolio Co Reports Positive Results From Clinical Study Of Drug Candidate
Brief: Karolinska Development's Portfolio Company Reports Promising Preclinical Results For Candidate Drug
Brief: Karolinska Development's Portfolio Company OssDsign Gets FDA Clearance For New Major Indication
Brief: Karolinska Development Q2 Net Results Swings To Profit SEK 23.3 Mln